SCHEMBL1993899

SCHEMBL1993899

CCOC(=O)Cc1nn(CC2CCN(C(=O)OC(C)(C)C)CC2)c2ccccc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.48
RECQL P46063 1/20 0.47
MERTK Q12866 1/20 0.45
KDM4E B2RXH2 2/20 0.44
ALDH1A1 P00352 2/20 0.44
PKM P14618 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.43
CHRM2 P08172 1/20 0.42
CHRM4 P08173 1/20 0.42
CHRM1 P11229 1/20 0.42
CHRM3 P20309 1/20 0.42
LMNA P02545 2/20 0.42
THRB P10828 1/20 0.42
PIK3CD O00329 1/20 0.42
PIK3R2 O00459 1/20 0.42
PIK3CA P42336 1/20 0.42
PIK3CB P42338 1/20 0.42
PIK3CG P48736 1/20 0.42
PIK3R5 Q8WYR1 1/20 0.42
PIK3R3 Q92569 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1994908 0.91 L3MBTL1 (0.50) L3MBTL1RECQLALDH1A1SMN1; SMN2CHRM2
SCHEMBL1992840 0.88 KDM4E (0.46) MERTKKDM4EPKMSMN1; SMN2CHRM2
SCHEMBL1991437 0.86 L3MBTL1 (0.44) L3MBTL1RECQLALDH1A1SMN1; SMN2CHRM2
SCHEMBL1991434 0.86 L3MBTL1 (0.44) L3MBTL1RECQLALDH1A1SMN1; SMN2CHRM2
SCHEMBL1998303 0.85 RECQL (0.53) RECQLALDH1A1SMN1; SMN2
SCHEMBL2002226 0.85 L3MBTL1 (0.50) L3MBTL1RECQLKDM4EALDH1A1PKM
SCHEMBL1997456 0.84 RECQL (0.55) RECQLALDH1A1SMN1; SMN2
SCHEMBL1994772 0.83 KDM4E (0.44) L3MBTL1MERTKKDM4EPKMCHRM2
SCHEMBL1996881 0.83 L3MBTL1 (0.48) L3MBTL1RECQLKDM4EALDH1A1SMN1; SMN2
SCHEMBL1991871 0.83 L3MBTL1 (0.48) L3MBTL1RECQLALDH1A1SMN1; SMN2CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110152243-A1 NOVEL THIENOPYRROLE COMPOUNDS ABBOTT LABORATORIES (US) 2011-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110152243-A1 NOVEL THIENOPYRROLE COMPOUNDS TPMT, TSLP, THPO L3MBTL1 3898/4885RECQL 3604/4885MERTK 1792/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.